Bronchiectasis is a chronic lung condition in which the airways (bronchi) become permanently widened and damaged, making it difficult to clear mucus. This trapped mucus creates a breeding ground for repeated infections, which cause more inflammation and more damage, gradually worsening the condition over time. It affects roughly 139 per 100,000 adults in the United States, though global estimates vary widely and the condition is increasingly recognized as underdiagnosed.
How Bronchiectasis Develops
Healthy airways are lined with tiny hair-like structures called cilia that sweep mucus and trapped particles up and out of the lungs. In bronchiectasis, something disrupts this cleaning system. Mucus builds up, bacteria settle in, and the immune system responds with inflammation. That inflammation damages the elastic walls of the airways, stretching them out permanently. The widened, floppy airways are even worse at clearing mucus, so the cycle repeats.
Pulmonologists call this the “vicious cycle” or “vicious vortex”: impaired mucus clearance leads to infection, infection triggers inflammation, inflammation causes structural damage, and structural damage further impairs mucus clearance. Once the cycle is established, it tends to be self-perpetuating. Treatment focuses on breaking into this loop at multiple points rather than reversing the damage that has already occurred.
Common Causes
Cystic fibrosis accounts for nearly half of all bronchiectasis cases in the United States, particularly in children. But many people develop what’s called non-cystic fibrosis bronchiectasis, which has a long list of possible triggers. The most common include:
- Severe or repeated lung infections. A bad case of pneumonia, whooping cough, or tuberculosis earlier in life can leave lasting airway damage. Infections from nontuberculous mycobacteria (NTM), organisms found in soil, dust, and water, are also closely linked.
- Immune system disorders. Conditions like common variable immunodeficiency (CVID) leave the body unable to fight off respiratory infections effectively, allowing repeated damage to accumulate.
- Primary ciliary dyskinesia. This inherited condition means the cilia lining the airways don’t move properly from birth, so mucus is never cleared efficiently.
- Autoimmune and inflammatory diseases. Conditions like rheumatoid arthritis and inflammatory bowel disease are associated with bronchiectasis, though the exact connection isn’t always clear.
In a significant number of cases, no specific cause is ever identified. These are labeled “idiopathic,” and they’re managed the same way regardless.
What It Feels Like
The hallmark symptom is a persistent, productive cough. In clinical studies, cough is reported by about 98% of people with bronchiectasis, and roughly 78% regularly cough up sputum, which is typically mucoid and relatively odorless. Shortness of breath affects about 62% of patients, and coughing up blood (hemoptysis) is surprisingly common, reported in 56% to 92% of cases depending on the study. About 20% experience chest pain, usually from the strain of chronic coughing rather than from the lungs themselves.
The day-to-day experience varies enormously. Some people produce a small amount of mucus each morning and otherwise feel fine. Others deal with large volumes of thick sputum, frequent chest infections, and fatigue that limits daily activities. Flare-ups, called pulmonary exacerbations, bring a noticeable increase in symptoms over several days: more cough, more sputum (often changing color), increased breathlessness, and sometimes fever. These episodes typically require a course of antibiotics targeted at whatever bacteria are growing in the airways.
How It’s Diagnosed
A high-resolution CT scan of the chest is the standard tool. Doctors look for airways that are wider than the blood vessel running alongside them. The technical measurement is the broncho-arterial ratio: if the airway’s inner diameter is larger than the adjacent artery (a ratio greater than 1), bronchiectasis is suspected. For maximum diagnostic certainty, radiologists look for a ratio of 1.5 or higher, since mild dilation can sometimes appear in healthy people. Other signs on the scan include airway walls that appear thickened and airways that remain visible far out toward the edges of the lung, where they normally taper and disappear.
Beyond the scan, your doctor will likely run tests to look for an underlying cause. This often includes blood work to check immune function, sputum cultures to identify which bacteria are present, and sometimes genetic testing if cystic fibrosis or ciliary dyskinesia is suspected. Lung function tests (spirometry) help establish a baseline and track changes over time.
Treatment and Daily Management
There is no cure for bronchiectasis, but consistent management can slow progression, reduce infections, and significantly improve quality of life. The cornerstone of treatment is airway clearance: physically helping mucus move out of the damaged airways so it doesn’t sit there feeding infections.
Airway clearance techniques come in several forms. Some people use handheld devices that create resistance when you breathe out (positive expiratory pressure devices), vibrating the airways to shake mucus loose. Others use oscillating vests that rapidly compress and release the chest wall. Simpler manual approaches include postural drainage (positioning your body so gravity helps mucus flow toward larger airways where it can be coughed out), chest percussion (rhythmic clapping on the chest), and structured breathing patterns known as active cycle breathing techniques. Most people with bronchiectasis do some form of airway clearance daily, and finding the right method often takes some trial and error with a respiratory physiotherapist.
For people who continue to have frequent flare-ups despite regular airway clearance, long-term antibiotic therapy may be recommended. European Respiratory Society guidelines suggest this for patients experiencing two or more exacerbations per year, or at least one severe exacerbation, or one exacerbation combined with significant daily symptoms. The most commonly used option is azithromycin, taken either daily or three times per week at a low dose, primarily for its anti-inflammatory properties rather than just its antibiotic effect. Before starting, doctors should rule out NTM infection, because using a single antibiotic against NTM can breed resistance and make that infection much harder to treat later.
Exercise matters too. Regular physical activity helps loosen mucus and maintain lung capacity. Many pulmonary rehabilitation programs combine supervised exercise with education on managing the condition.
What Affects Long-Term Outlook
Bronchiectasis is a lifelong condition, but its trajectory varies widely. Some people remain stable for decades with minimal treatment. Others experience progressive decline, particularly if they develop chronic colonization with certain bacteria.
Research using the Bronchiectasis Severity Index has identified several factors linked to worse outcomes. The strongest predictor of future hospitalization is having been hospitalized before. Severe breathlessness, very low lung function, and colonization with a bacterium called Pseudomonas aeruginosa also significantly increase the risk of hospital admissions. For mortality, the key risk factors are older age, low body weight (BMI under 18.5), reduced lung function, prior hospitalizations, and having three or more exacerbations per year.
The practical takeaway is that preventing exacerbations is the single most important goal. Each flare-up causes additional airway damage, feeds the vicious cycle, and increases the risk of the next one. People who stick with daily airway clearance, stay on top of infections early, keep up with vaccinations (flu and pneumonia), and maintain physical fitness tend to have the best outcomes over time.